Hong Kong Stock Exchange disclosures reveal that on September 16, Chairman and Chief Executive Officer Wu Yusheng increased his stake in TYK MEDICINES-B (02410), acquiring 120,000 shares at a price of HK$3.486 per share, totaling approximately HK$418,300.
Following the transaction, Wu's latest shareholding stands at around 125 million shares, representing a 32.89% stake in the company.
This move underscores the leadership's confidence in the pharmaceutical firm's prospects as it continues to advance its pipeline and operational strategies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments